Claudia Crosio, PhD, earned her PhD in molecular biology at the University of Rome "Tor Vergata" (Italy). She worked as a postdoctoral fellow at the IGMC in Strasbourg (France), in Paolo Sassone-Corsi’s lab, on epigenetic modifications involved in a variety of cellular processes and model systems (in fibroblasts derived from a patient affected by the Coffin-Lowry Syndrome to the mammalian circadian clock and spermatogenesis). She then returned to Italy, where she started working on molecular mechanisms operating in the pathogenesis of amyotrophic lateral sclerosis, focusing on the development of new tools to understand the biochemical properties of different ALS-causing gene mutants expressed in a neuronal environment. After joining the University of Sassari in 2005 she extended her scientific interest to Parkinson’s disease, focusing on LRRK2-role in neuron physiopathology.